Understanding How Health Insurance Affects Equity in Access to Care for Individuals Diagnosed with Blood Cancer

The Blood Cancer United Equity in Access Research Program supports research examining how health insurance status, type, design, and policy changes affect equitable access to care for people diagnosed with blood cancer. Funded research should identify insurance-related barriers and develop actionable solutions that can inform policy reform, healthcare practices, and program delivery. This opportunity is most relevant to research organizations and community-based organizations with established research capacity or partnerships with universities, cancer centers, healthcare systems, or other research institutions.